Idiopathic hypereosinophilic syndrome

Search Trials
Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
Status:
Active, not recruiting
Last Changed:
Feb 8, 2022
First Changed:
May 6, 2014
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
benralizumabPlacebo
A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
Status:
Terminated
Last Changed:
May 1, 2012
First Changed:
Sep 15, 2005
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
imatinib mesylate
Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Status:
Terminated
Last Changed:
Jul 7, 2017
First Changed:
Nov 23, 2004
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
mepolizumab
Identification of New Markers in the Hypereosinophilic Syndrome
Status:
Completed
Last Changed:
Feb 15, 2019
First Changed:
Oct 24, 2012
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
biologie sample
Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Status:
Unknown status
Last Changed:
Dec 7, 2017
First Changed:
Apr 2, 2014
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
Dexpramipexole

Connect. Empower. Inspire.